← Eichor
Condition: Substance Use Treatment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Substance Use Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Semaglutide for Helping Opioid Recovery
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT06639464Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07318480Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
NA · 1 location(s) · Emory University · NCT05711056tDCS Plus Varenicline for Smoking Cessation
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT06798324Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
Phase 1 · 1 location(s) · University of Minnesota · NCT07158853Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06883097Translation and Validation of the COMM and ASI-SR
Phase N/A · 1 location(s) · Uppsala University · NCT06084520BREATHE Free: a Pilot Feasibility Trial
NA · 1 location(s) · Augusta University · NCT06862050LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
Phase 2 · 1 location(s) · NYU Langone Health · NCT03667846Smoking Cessation Behavioral Treatment Study
NA · 2 location(s) · University of Missouri-Columbia · NCT03948893Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
NA · 1 location(s) · Potomac Health Foundations · NCT06774248Re-Connect Application for Smoking Cessation
NA · 1 location(s) · Rowan University · NCT05224154Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders
NA · 1 location(s) · The Mind Research Network · NCT06981351Standard Versus High Dose ED-Initiated Buprenorphine Induction
Phase 3 · 5 location(s) · Yale University · NCT06494904Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826Virtual Incentive Treatment for Alcohol
NA · 1 location(s) · Washington State University · NCT06265506Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06558825Accelerated rTMS for Substance Use Disorder and Depression
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06424184Optimization of NIBS for Treatment of Addiction
NA · 3 location(s) · Case Western Reserve University · NCT04379115Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START
NA · 1 location(s) · Ohio State University · NCT07278427Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev
NA · 1 location(s) · Chestnut Health Systems · NCT06852170Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training
NA · 1 location(s) · Brown University · NCT07713251Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Phase 3 · 1 location(s) · Jasper A. Smits · NCT06053567Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
Phase N/A · 2 location(s) · University of Southern California · NCT07186699Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
NA · 4 location(s) · University of Maryland, College Park · NCT05973838Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients
NA · 1 location(s) · Nova Scotia Health Authority · NCT05365347Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Phase 2 · 1 location(s) · Brugmann University Hospital · NCT06160232Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso
NA · 1 location(s) · Geisinger Clinic · NCT07197801Alcohol, Psychoactive Drugs, Analgesics and Evaluation in Penetrating Abdominal Trauma
Phase N/A · 2 location(s) · Fundacion Clinica Valle del Lili · NCT07330349
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.